Abstract:Healthy state is priority in today's world which can be achieved using effective medicines. But due to overuse and misuse of antibiotics, a menace of resistance has increased in pathogenic microbes. World Health Organization (WHO) has announced ESKAPE pathogens ( Enterococcus faecium , Staphylococcus aureus, Klebsiella pneumoniae, Acinetobacter baumannii, Pseudomonas aeruginosa, and Enterobacter spp.) as the top priority pathogens as these have developed resistance against certain antibiotics. To combat such a global issue, it is utmost important to identify novel therapeutic strategies/agents as an alternate to such antibiotics. To name certain antibiotic adjuvants including: inhibitors of beta–lactamase, efflux pumps and permeabilizers for outer membrane can potentially solve the antibiotic resistance problems. In this regard, inhibitors of lytic domain of lytic transglycosylases provide a novel way to not only act as an alternate to antibiotics but also capable of restoring the efficiency of previously resistant antibiotics. Further, use of bacteriophages is another promising strategy to deal with antibiotic resistant pathogens. Taking in consideration the alternatives of antibiotics, a green synthesis nanoparticle-based therapy exemplifies a good option to combat microbial resistance. As horizontal gene transfer (HGT) in bacteria facilitates the evolution of new resistance strains, therefore identifying the mechanism of resistance and development of inhibitors against it can be a novel approach to combat such problems. In our perspective, host-directed therapy (HDT) represents another promising strategy in combating antimicrobial resistance (AMR). This approach involves targeting specific factors within host cells that pathogens rely on for their survival, either through replication or persistence. As many new drugs are under clinical trials it is advisable that more clinical data and antimicrobial stewardship programs should be conducted to fully assess the clinical efficacy and safety of new therapeutic agents.

Combatting antimicrobial resistance via the cysteine biosynthesis pathway in bacterial pathogens

Targeting the cysteine biosynthesis pathway: Mechanism, structure, and drug discovery

Antimicrobials: An update on new strategies to diversify treatment for bacterial infections

Combating bacterial resistance by combination of antibiotics with antimicrobial peptides

Multiplexing bacteriocin synthesis to kill and prevent antimicrobial resistance

Antibiotic resistance: The challenges and some emerging strategies for tackling a global menace

Towards the sustainable discovery and development of new antibiotics

Combating Antimicrobial Resistance by Employing Antimicrobial Peptides: Immunomodulators and Therapeutic Agents against Infectious Diseases

Exploring Phytochemicals for Combating Antibiotic Resistance in Microbial Pathogens

Inhibitors of the sulfur assimilation pathway in bacterial pathogens as enhancers of antibiotic therapy

Combating antimicrobial resistance: the silent war

Progress in Alternative Strategies to Combat Antimicrobial Resistance: Focus on Antibiotics

Antimicrobial Peptides: A Promising Solution to the Rising Threat of Antibiotic Resistance

Antibiotic resistance: a global crisis, problems and solutions

Fighting Antimicrobial Resistance: Innovative Drugs in Antibacterial Research

Mechanism-guided strategies for combating antibiotic resistance

Computer-aided drug design to generate a unique antibiotic family

Natural antibiotics against antimicrobial resistance: sources and bioinspired delivery systems

Endophytes: a uniquely tailored source of potential antibiotic adjuvants

Bacteriocins, Potent Antimicrobial Peptides and the Fight against Multi Drug Resistant Species: Resistance Is Futile?

Plant-Derived Antimicrobials and Their Crucial Role in Combating Antimicrobial Resistance